Exin Therapeutics Analysis: $500K Raised
What is Exin Therapeutics?
Exin Therapeutics develops AI-driven therapeutics for neurological disorders, focusing on conditions like epilepsy, autism spectrum disorder, and Parkinson’s disease.
Founded
2024
Description (YC)
AI drug discovery platform for neurotherapeutics
Tag (YC)
Healthcare
Product Features & Capabilities
- target discovery platform for neurotherapeutics, utilizes multimodal AI, predicts drug candidates' potential across multiple neural disorders, multi-target effect, highly localized, agnostic to genetic background
How much Exin Therapeutics raised
Pre-Seed - $500,000
January 21, 2025Lead Investor: Y Combinator
See something that needs updating? Suggest edits to this profile.